Please use this identifier to cite or link to this item:
http://elar.urfu.ru/handle/10995/130967
Title: | Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides |
Authors: | Krasnov, V. P. Nizova, I. A. Vigorov, A. Y. Matveeva, T. V. Levit, G. L. Kodess, M. I. Ezhikova, M. A. Slepukhin, P. A. Bakulin, D. A. Tyurenkov, I. N. Charushin, V. N. |
Issue Date: | 2023 |
Publisher: | Multidisciplinary Digital Publishing Institute (MDPI) |
Citation: | Krasnov, V, Nizova, I, Vigorov, A, Matveeva, T, Levit, G, Kodess, M, Ezhikova, M, Slepukhin, P, Bakulin, D, Tyurenkov, I & Charushin, V 2023, 'Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides', Molecules, Том. 28, № 21, 7401. https://doi.org/10.3390/molecules28217401 Krasnov, V., Nizova, I., Vigorov, A., Matveeva, T., Levit, G., Kodess, M., Ezhikova, M., Slepukhin, P., Bakulin, D., Tyurenkov, I., & Charushin, V. (2023). Synthesis and Assessment of Antiplatelet and Antithrombotic Activity of 4-Amino-Substituted 5-Oxoproline Amides and Peptides. Molecules, 28(21), [7401]. https://doi.org/10.3390/molecules28217401 |
Abstract: | Venous thromboembolism is a serious problem because it significantly increases the risk of developing vascular complications in elderly patients with obesity or immobilization, cancer, and many other diseases. Thus, there is a need to study new therapeutic strategies, including new medicinal agents for the efficient and safe correction of thrombus disorders. In this work, we have synthesized a number of new amides and peptides of 4-amino-5-oxoprolines and studied their antiplatelet and antithrombotic activity in experiments in vitro and in vivo. It has been found that the newly obtained compounds slow down the process of thrombus formation in a model of arterial and venous thrombosis, without affecting plasma hemostasis parameters. (2S,4S)-4-Amino-1-(4-fluorophenyl)-5-oxoprolyl-(S)-phenylalanine proved to be the most efficient among the studied derivatives. The results obtained indicate the advisability of further studies on 5-oxoproline derivatives in order to design pharmaceutical agents for the prevention and treatment of the consequences of thrombosis. © 2023 by the authors. |
Keywords: | 5-OXOPROLINE AMIDES HISTIDINE IN VIVO EXPERIMENTS MORPHOLINE PEPTIDES PHENYLALANINE PIPERIDINE PYROGLUTAMIC ACID AMIDE ANTITHROMBOCYTIC AGENT FIBRINOLYTIC AGENT PEPTIDE PYROGLUTAMIC ACID AGED CHEMISTRY HUMAN THROMBOSIS AGED AMIDES FIBRINOLYTIC AGENTS HUMANS PEPTIDES PLATELET AGGREGATION INHIBITORS PYRROLIDONECARBOXYLIC ACID THROMBOSIS |
URI: | http://elar.urfu.ru/handle/10995/130967 |
Access: | info:eu-repo/semantics/openAccess cc-by |
License text: | https://creativecommons.org/licenses/by/4.0/ |
SCOPUS ID: | 85176608417 |
WOS ID: | 001099550100001 |
PURE ID: | 48542552 |
ISSN: | 1420-3049 |
DOI: | 10.3390/molecules28217401 |
Sponsorship: | Ministry of Science and Higher Education of the Russian Federation: 075-15-2020-777 This research was funded by the Ministry of Science and Higher Education of Russia (agreement no. 075-15-2020-777 of 1 October 2020). |
Appears in Collections: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2-s2.0-85176608417.pdf | 2,57 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License